Abstract
Aim:
To investigate the effects of triptolide, a diterpenoid triepoxide from Tripterygium wilfordii Hook F (TWHF), on the co-stimulatory molecule expression and interleukin-12 (IL-12) production from THP-1 cells.
Methods:
THP-1 cells were differentiated into macrophage-like cells by Me2SO, and then cultured with IFN-γ (500 kU/L) and lipopolysaccharide (LPS) (1 mg/L) with or without triptolide. The surface molecule expressions were analyzed on a FACScan flow cytometer. IL-12p40, IL-12p70 were assayed by ELISA.
Results:
Tripolide suppressed CD80 and CD86 expressions on IFN-γ (500 kU/L) and LPS (1 mg/L) activated THP-1 cells at nontoxic dosages of 2.5–0.625 μg/L. Furthermore, the production of IL-12p40 and IL-12p70 were also significantly reduced in THP-1 cells exposed to triptolide.
Conclusion:
Triptolide impairs the antigen-presenting function by inhibiting CD80 and CD86 expressions and decreased IL-12p40 and IL-12p70 (bioactive form) productions from the activated THP-1 cells.
Similar content being viewed by others
Article PDF
References
Schwartz RH . T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 1985; 3: 237–61.
Greenfield EA, Nguyen KA, Kuchroo VK . CD28/B7 costimulation. Crit Rev Immunol 1998; 18: 389–418.
Salomon B, Bluestone JA . Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225–52.
Jonker M, Ossevoort And MA, Vierboom M . Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models. Transplantation 2002; 73: S23–6.
Anand S, Chen L . Control of autoimmune diseases by the B7-CD28 family molecules. Curr Pharm Des 2004; 10: 121–8.
Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, et al. Clinical and histologic response to singledose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody. J Am Acad Dermatol 2002; 47: 692–700.
Tao XL, Sun Y, Dong Y, Xiao YL, Hu DW, Shi YP, et al. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin Med J 1989; 102: 327–32.
Lipsky PE, Tao XL . A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 1997; 26: 713–23.
Qiu D, Kao PN . Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook f. Drugs R D 2003; 4: 1–18.
Su D, Song Y, Li R . Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii. Chin J Integrated Trad West Med 1990; 10: 144–6.
Gu WZ, Brandwein SR . Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol 1998; 20: 389–400.
Li L, Wakukami T, Teng WP, Di GX, Murakami K, Mimura G . The effect of triptolide on the development of insulitis in lowdose streptozotocin induced diabetic mice and on the beta-cells of normal mice. Chin J Diabetes 1994; 2: 69–75.
Yi ZW, Li L . Clinical study of nephrotic syndrome in children treated by triptolide. Hunan Med J 1994; 11: 284–5.
Lu H, Hachida M, Enosawa S, Li XK, Suzuki S, Koyanagi H . Immunosuppressive effect of triptolide in vitro. Transplant Proc 1999; 31: 2056–7.
Chan MA, Kohlmeier JE, Branden M, Jung M, Benedict SH . Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. Phytother Res 1999; 13: 464–7.
Yang Y, Liu Z, Tolosa E, Yang J, Li L . Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 1998; 40: 139–49.
Hong Y, Zhou W, Li K, Sacks SH . Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 2002; 62: 1291–300.
Li H, Liu ZH, Dai CS, Liu D, Li LS . Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells. Acta Pharmacol Sin 2002; 23: 775–81.
Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16: 495–521.
Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 1983; 65: 55–63.
Kubin M, Chow JM, Trinchieri G . Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 1994; 83: 1847–55.
Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B . The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response. Int Immunopharmacol 2003; 3: 1457–65.
Lin JF, Zhu H, Liu XQ, Zhen HP, Zheng YL . Triptolide prolong the survival of heart transplant in mice. Strait Pharmacentical J 1998; 10: 29–30.
Yang J, Fan Z, Dai C, Wang J, Liu Z, Li L . Antirenal allograft rejection effects of triptolide in rats. J Nephrol Dialy Trans plant 1997; 6: 214–20.
Chen BJ, Liu C, Cui X, Fidler JM, Chao NJ . Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation 2000; 70: 1442–7.
Du ZY, Li XY, Li YC, Wang SY . Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray. Acta Pharmacol Sin 2003; 24: 864–72.
Monteyne P, Guillaume B, Sindic CJ . B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients. J Neuroimmunol 1998; 91: 198–203.
Liu H, Liu ZH, Chen ZH, Yang JW, Li LS . Triptolide: a potent inhibitor of NF-kappa B in T-lymphocytes. Acta Pharmacol Sin 2000; 21: 782–6.
Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 1999; 274: 13443–50.
Caamano J, Hunter CA . NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002; 15: 414–29.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No A30171086) and the Knowledge Innovation Program of the Chinese Academy of Sciences (No KSCX2-SW-202).
Rights and permissions
About this article
Cite this article
Liu, J., Wu, Ql., Feng, Yh. et al. Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells. Acta Pharmacol Sin 26, 223–227 (2005). https://doi.org/10.1111/j.1745-7254.2005.00035.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00035.x
Keywords
This article is cited by
-
Triptolide prevents osteoarthritis via inhibiting hsa-miR-20b
Inflammopharmacology (2019)
-
Identification of geranylgeranyl diphosphate synthase genes from Tripterygium wilfordii
Plant Cell Reports (2015)